Shelly Kagan is Clark Professor of Philosophy at Yale, and he teaches a great class about death – PHIL 176: Death. You don’t need to have high SAT scores in order to attend this class, nor do you need to reside in Connecticut. Using the power of the Internet, anyone on this planet can attend his […]
“The Post-Antibiotic Era Is Here. Now What?” was the title of an article by Wired a few years back which talked about how more and more people are getting knocked off by antibiotic-resistant bacteria. In other words, we’ve now entered a “post antibiotic era.” In an article last year titled Can We Kill Antibiotic-Resistant Superbugs?, we […]
According to Deloitte, some of the key drivers for life sciences in 2020 will be data-driven approaches that employ machine learning and AI, the use of sensors and wearables for telemedicine and predictive medicine, and precision medicine supported by new cell and gene therapies. For years, we’ve been reading about these superb innovations and what […]
Anyone who has worked in information technology for a while knows about the old “diapers and beer” story which a fellow named Mark Madsen actually got to the bottom of a few years ago. The story goes something like this. Back in the early 90s, a woman named Karen Heath, a senior manager for health analytics with Accenture […]
According to Deloitte, global healthcare spending is expected to increase at an annual rate of 5.4% between 2017-2022, from $7.7 trillion to $10.1 trillion. Aging societies, global population growth, and an increase in life expectancy thanks to a burgeoning longevity industry are all putting a strain on existing healthcare systems. All the while, non-communicable diseases […]
Somewhere in a coffee shop in America, some green-haired millennial is typing away feverishly on their brand new Macbook Air, broadcasting to their Twitter followers about how evil capitalism is. As they pour a dab of pasture-grazed New Zealand cow’s milk into their freshly roasted cup of Guatemalan organic free-trade coffee, they lament their woes […]
Investors in Illumina must be stoked about how things have been going so far for a company that commands a dominant market share in one of the most transformative technologies of our time – genetic sequencing. It’s allowed us to pursue promising technologies like gene editing – and now base editing – which means we can start […]
You probably don’t know much about rare diseases unless you’re one of the unfortunate few who are afflicted by one. Not everyone agrees upon how we ought to define a rare disease, but in the United States, that’s considered one that affects less than 200,000 people or about 1 in 1,636 people. While some diseases […]
While we’re still a couple of months out from the release of the final installment of the Star Wars triple trilogy, you can already buy tickets to watch the good guys blow up the Death Star for the fifth or sixth time (we’ve lost count). The 42-year-old franchise has raked in more than $9.3 billion […]
The history of direct-to-consumer genomics tests goes something like this. Genomics startups first started offering hereditary tests that required a DNA sample and everyone quickly climbed on board without realizing just how much information they were handing over to people they didn’t really know that well. Eventually, testing companies started moving into DNA health tests and then the FDA […]
Don’t have your M.D.?